Clik here to view.
Pharma Industry Booming in Eastern Europe
Eastern Europe’s pharmaceutical market is forecast to grow at a CAGR of more than 10 percent to be worth more than $41 billion by 2014, according to a report from globalbusinessinsights.com. The...
View ArticleClik here to view.
Pharma Celebrates its Own
At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage. “The most successful new [cancer] therapies will be based on a precise...
View ArticleClik here to view.
Health Reform Hazards: Steering Your Course Through the Rhetorical Shallows
Image by Getty Images via Dayli Crafting consensus legislation on health reform depends heavily on all parties understanding precisely the terms of the debate. With the two House and Senate bills now...
View ArticleClik here to view.
FDA and GSK on the Hunt for Stolen Drugs
Image by Johnny Grim via Flickr We typically don’t get emails from FDA asking for information about stolen goods with massive bold letters, but that’s what just came into our inbox. Looks like a...
View ArticleClik here to view.
Upcoming Webcast: The Visibility Solution
The Visibility Solution: Delivering an Accurate View of Clinical Operations Thursday, April 1, 2010 at 11:00 AM PT; 2:00 PM ET; 16:00 GMT This event focuses on our Clinical Trials solution with...
View ArticleClik here to view.
BIO Convention: Potemkin Pavilions and the Power of NICE
Image by Getty Images via Daylife Last week’s annual meeting of BIO in Chicago once again proved illustrative in showcasing the high profile that governments now plays as the biotech sector’s chief...
View ArticleClik here to view.
Takeda Launches New Plan, Cuts US Jobs
Image via Wikipedia The Japanese are taking a play from the US pharmaceutical industry’s rulebook and restructuring itself under the auspices of a fun catch phrase: “Transformation for a New Takeda.”...
View ArticleClik here to view.
Industry and FDA Brace for Change
Janet Woodcock While the convention floor of the 46th annual meeting of the Drug Information Association bustled with the usual vendors touting the latest and greatest clinical trial technology, the...
View ArticleClik here to view.
GSK Scores High in Market Access
ACCESS TO MEDICINE INDEX 2010 GlaxoSmithKline ranked number one in a study of pharmaceutical companies offering access to medicines to emerging and developing nations, proving that the UK drug giant...
View ArticleEurope: Resisting the Anticompetitive Crusade
It’s been another rocky few weeks for pharma in Europe. Particularly for big brand name companies. But necessity is proving the mother of invention, says Pharm Exec’s Brussels correspondent, Reflector....
View Article
